Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 09, 2018
Supply Chain Wizard and Epista Life Science ApS have partnered to support their clients beyond serialization compliance deadlines.
read more
Epistem announces that following investment by Foresight Group it has completed a management buy-out (MBO) from genedrive plc.
read more
EpiVax, Inc. announces participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2. EpiVax will be carrying out the vaccine...
read more
Epizyme, Inc. has entered into two Cooperative Research and Development Agreements (CRADAs) with the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). The CRADAs will evaluate tazemetostat, Epizyme’s first-in-class EZH2...
read more
Eppendorf expands its portfolio of rigid-wall single-use vessels for fermentation. The newly launched Eppendorf BioBLU® 3f was developed specifically for microbial bioprocessing in working volumes of 1.25 to 3.75 L, extending the full range of ...
read more
Monday, September 22, 2014
The rise of high value specialty pharmaceuticals, growth of the generics market, smaller order sizes and increasing label complexity are driving demand for shorter batch color labels. With the Drug Quality and Security Act’s (DQSA) impending ...
read more
Thursday, November 18, 2021
EQRx, and Evotec SE announced a collaboration to design, discover and develop new therapeutic options for patients. The collaboration will help accelerate EQRx’s pipeline expansion efforts by leveraging Evotec’s unique data-driven, fully integrated R...
read more
Eremid Research Services has been established as the new name for the commercial arm of the 501(c)(3) non-profit, research organization - DHMRI.
read more
Monday, December 21, 2020
Ergomed has announced the acquisition of MS Clinical Services, a specialized CRO based in Houston, Texas.
read more
ERS Genomics Limited announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS’ CRISPR/Cas9 patent portfolio.
read more
CRISPR offerings to enhance NUVISAN’s drug development service portfolio.
read more
ERS Genomics has announced the signing of a license agreement with Otsuka Pharmaceutical.
read more
Monday, September 21, 2020
ERS Genomics has signed an agreement with Applied StemCell, a provider of stem cell, animal model, antibody discovery services and reagents.
read more
ERS Genomics announced the signing of a license agreement granting Axxam access to ERS Genomics' CRISPR-Cas9 patent portfolio, to support Axxam's integrated discovery service platform.
read more
Friday, November 10, 2017
ERS Genomics and Cellecta announced a non-exclusive license agreement to provide Cellecta worldwide access to ERS Genomics' CRISPR/Cas9 genome editing intellectual.
read more